Michael Merger
Impact in
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Gastrointestinal motility and disorders 3
- Celiac Disease Research and Management 2
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Heinz J. Kilbinger (1 shared paper)Alexander Gebauer (1 shared paper)Jan Marc Orenstein (2 shared papers)Martin F. Graham (2 shared papers)Phillip D. Coleridge Smith (2 shared papers)Don A. Sibley (1 shared paper)Hiromi Kubagawa (1 shared paper)Michael W. Russell (1 shared paper)
In The Last Decade
Michael Merger
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 83
- Gastroenterology 89
- Reproductive Medicine 134
- Immunology 322
- Virology 37
- Oncology 168
Countries citing papers authored by Michael Merger
This map shows the geographic impact of Michael Merger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Merger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Merger more than expected).
Fields of papers citing papers by Michael Merger
This network shows the impact of papers produced by Michael Merger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Merger. The network helps show where Michael Merger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Merger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 282 | |
| 2 | 2011 | 181 | |
| 3 | 1993 | 124 | |
| 4 | 1997 | 91 | |
| 5 | 2002 | 90 | |
| 6 | 2012 | 74 | |
| 7 | 2002 | 46 | |
| 8 | 2019 | 43 | |
| 9 | Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer. | 2011 | 38 |
| 10 | 1999 | 34 | |
| 11 | Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins. | 2007 | 18 |
| 12 | 1998 | 17 | |
| 13 | 2006 | 12 | |
| 14 | 2014 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2008 | 2 | |
| 17 | 2005 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2003 | 1 | |
| 20 | 2008 | 0 |
About Michael Merger
Michael Merger is a scholar working on Gastroenterology, Reproductive Medicine, Hepatology, Pulmonary and Respiratory Medicine and Immunology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Gastrointestinal motility and disorders (3 papers), Cancer Mechanisms and Therapy (2 papers), Microscopic Colitis (2 papers), Celiac Disease Research and Management (2 papers), Renal cell carcinoma treatment (2 papers), Inflammatory Bowel Disease (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Gastroenterology (89 citations), Reproductive Medicine (134 citations), Immunology (322 citations), Virology (37 citations) and Oncology (168 citations). Michael Merger has collaborated with scholars based in Germany, France and Canada. Frequent co-authors include Heinz J. Kilbinger, Alexander Gebauer, Jan Marc Orenstein, Martin F. Graham, Phillip D. Coleridge Smith, Don A. Sibley, Hiromi Kubagawa, Michael W. Russell, Marty T. Sellers and Toshihide Shimada. Their work appears in journals such as Gut, Journal of Immunological Methods, Gynecologic Oncology, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.